Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Munn

Showing results (91-100 of 185) with videos related to

Pageof 19
Sort By:
Oncoimmunology|December 25, 2012
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophanRichard Metz, Sonja Rust, James B Duhadaway, et al.
Blood|June 18, 2005
Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitisRaghava Potula, Larisa Poluektova, Bryan Knipe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2010
Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunizationQifeng Zhou, Haiyan Xiao, Yanjun Liu, et al.
Circulation Research|September 1, 1996
Monocyte- and cytokine-induced downregulation of angiotensin-converting enzyme in cultured human and porcine endothelial cellsA Papapetropoulos, A Antonov, R Virmani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2013
Local administration of TLR ligands rescues the function of tumor-infiltrating CD8 T cells and enhances the antitumor effect of lentivector immunizationHaiyan Xiao, Yibing Peng, Yuan Hong, et al.
International Immunology|September 8, 2004
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenaseAndrew L Mellor, Phillip Chandler, Babak Baban, et al.
Blood|April 16, 2009
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodesMadhav D Sharma, De-Yan Hou, Yanjun Liu, et al.
Cancer Research|January 20, 2007
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responsesDe-Yan Hou, Alexander J Muller, Madhav D Sharma, et al.
Journal of Leukocyte Biology|February 17, 2009
IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivoYoung H Kim, Beom K Choi, Woo J Kang, et al.
Scientific Reports|September 24, 2017
Adjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cellsZhi-Chun Ding, Tsadik Habtetsion, Yang Cao, et al.
Pageof 19

Showing results (91-100 of 185) with videos related to

Sort By:
Pageof 19
Oncoimmunology|December 25, 2012
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophanRichard Metz, Sonja Rust, James B Duhadaway, et al.
Blood|June 18, 2005
Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitisRaghava Potula, Larisa Poluektova, Bryan Knipe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2010
Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunizationQifeng Zhou, Haiyan Xiao, Yanjun Liu, et al.
Circulation Research|September 1, 1996
Monocyte- and cytokine-induced downregulation of angiotensin-converting enzyme in cultured human and porcine endothelial cellsA Papapetropoulos, A Antonov, R Virmani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2013
Local administration of TLR ligands rescues the function of tumor-infiltrating CD8 T cells and enhances the antitumor effect of lentivector immunizationHaiyan Xiao, Yibing Peng, Yuan Hong, et al.
International Immunology|September 8, 2004
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenaseAndrew L Mellor, Phillip Chandler, Babak Baban, et al.
Blood|April 16, 2009
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodesMadhav D Sharma, De-Yan Hou, Yanjun Liu, et al.
Cancer Research|January 20, 2007
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responsesDe-Yan Hou, Alexander J Muller, Madhav D Sharma, et al.
Journal of Leukocyte Biology|February 17, 2009
IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivoYoung H Kim, Beom K Choi, Woo J Kang, et al.
Scientific Reports|September 24, 2017
Adjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cellsZhi-Chun Ding, Tsadik Habtetsion, Yang Cao, et al.
Pageof 19